234 related articles for article (PubMed ID: 28013361)
1. Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.
Alam I; Reilly AM; Alkhouli M; Gerard-O'Riley RL; Kasipathi C; Oakes DK; Wright WB; Acton D; McQueen AK; Patel B; Lim KE; Robling AG; Econs MJ
Calcif Tissue Int; 2017 Apr; 100(4):361-373. PubMed ID: 28013361
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
3. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
4. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
5. WNT16 overexpression partly protects against glucocorticoid-induced bone loss.
Ohlsson C; Nilsson KH; Henning P; Wu J; Gustafsson KL; Poutanen M; Lerner UH; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E597-E604. PubMed ID: 29406783
[TBL] [Abstract][Full Text] [Related]
6. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
[TBL] [Abstract][Full Text] [Related]
7. The bone-sparing effects of estrogen and WNT16 are independent of each other.
Movérare-Skrtic S; Wu J; Henning P; Gustafsson KL; Sjögren K; Windahl SH; Koskela A; Tuukkanen J; Börjesson AE; Lagerquist MK; Lerner UH; Zhang FP; Gustafsson JÅ; Poutanen M; Ohlsson C
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14972-7. PubMed ID: 26627248
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice.
Alam I; Oakes DK; Reilly AM; Billingsley C; Sbeta S; Gerard-O'Riley RL; Acton D; Sato A; Bellido T; Econs MJ
JBMR Plus; 2019 Apr; 3(4):e10084. PubMed ID: 31044183
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
[TBL] [Abstract][Full Text] [Related]
10. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.
Xiao Z; Dallas M; Qiu N; Nicolella D; Cao L; Johnson M; Bonewald L; Quarles LD
FASEB J; 2011 Jul; 25(7):2418-32. PubMed ID: 21454365
[TBL] [Abstract][Full Text] [Related]
11. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
12. Skeletal phenotype of growing transgenic mice that express a function-perturbing form of beta1 integrin in osteoblasts.
Globus RK; Amblard D; Nishimura Y; Iwaniec UT; Kim JB; Almeida EA; Damsky CD; Wronski TJ; van der Meulen MC
Calcif Tissue Int; 2005 Jan; 76(1):39-49. PubMed ID: 15477996
[TBL] [Abstract][Full Text] [Related]
13. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk.
Zheng HF; Tobias JH; Duncan E; Evans DM; Eriksson J; Paternoster L; Yerges-Armstrong LM; Lehtimäki T; Bergström U; Kähönen M; Leo PJ; Raitakari O; Laaksonen M; Nicholson GC; Viikari J; Ladouceur M; Lyytikäinen LP; Medina-Gomez C; Rivadeneira F; Prince RL; Sievanen H; Leslie WD; Mellström D; Eisman JA; Movérare-Skrtic S; Goltzman D; Hanley DA; Jones G; St Pourcain B; Xiao Y; Timpson NJ; Smith GD; Reid IR; Ring SM; Sambrook PN; Karlsson M; Dennison EM; Kemp JP; Danoy P; Sayers A; Wilson SG; Nethander M; McCloskey E; Vandenput L; Eastell R; Liu J; Spector T; Mitchell BD; Streeten EA; Brommage R; Pettersson-Kymmer U; Brown MA; Ohlsson C; Richards JB; Lorentzon M
PLoS Genet; 2012 Jul; 8(7):e1002745. PubMed ID: 22792071
[TBL] [Abstract][Full Text] [Related]
14. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
15. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.
Triliana R; Lam NN; Sawyer RK; Atkins GJ; Morris HA; Anderson PH
J Steroid Biochem Mol Biol; 2016 Nov; 164():331-336. PubMed ID: 26343450
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
Movérare-Skrtic S; Henning P; Liu X; Nagano K; Saito H; Börjesson AE; Sjögren K; Windahl SH; Farman H; Kindlund B; Engdahl C; Koskela A; Zhang FP; Eriksson EE; Zaman F; Hammarstedt A; Isaksson H; Bally M; Kassem A; Lindholm C; Sandberg O; Aspenberg P; Sävendahl L; Feng JQ; Tuckermann J; Tuukkanen J; Poutanen M; Baron R; Lerner UH; Gori F; Ohlsson C
Nat Med; 2014 Nov; 20(11):1279-88. PubMed ID: 25306233
[TBL] [Abstract][Full Text] [Related]
17. Wnt16 Overexpression in Osteoblasts Increases the Subchondral Bone Mass but has no Impact on Osteoarthritis in Young Adult Female Mice.
Törnqvist AE; Grahnemo L; Nilsson KH; Funck-Brentano T; Ohlsson C; Movérare-Skrtic S
Calcif Tissue Int; 2020 Jul; 107(1):31-40. PubMed ID: 32140758
[TBL] [Abstract][Full Text] [Related]
18. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
19. Inducible
Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.
Windahl SH; Börjesson AE; Farman HH; Engdahl C; Movérare-Skrtic S; Sjögren K; Lagerquist MK; Kindblom JM; Koskela A; Tuukkanen J; Divieti Pajevic P; Feng JQ; Dahlman-Wright K; Antonson P; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2294-9. PubMed ID: 23345419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
